マシモがRad-97™ Pulse CO-Oximeter®でCEマークを取得
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、Rad-97™ Pulse CO-Oximeter®でCEマークを取得したと発表しました。Rad-97はRadical-7® Pulse CO-Oximeterと同じMeasure-through Motion and Low...
View Article免疫细胞治疗剂‘Immuncell-LC’,延长胶质母细胞瘤的无进展生存时间1.5倍
韩国首尔 (美国商业资讯)–以“以韩国人中最新确诊的胶质母细胞瘤患者为对象,并用标准疗法和基于CIK诱导杀伤细胞的细胞免疫治疗法的第三期随机临床试验(Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in...
View ArticleMasimo宣布Rad-97™脉搏碳氧-氧饱和度仪®获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布,Rad-97™脉搏碳氧-氧饱和度仪®获得CE标记。Rad-97在一个多功能的单机监护仪配置中提供同样的移动与低灌注下测量™ SET®脉搏氧饱和度仪和可升级的rainbow SET™技术作为Radical-7®脉搏碳氧-氧饱和度仪。 Smart News...
View ArticleCertara Establishes Phoenix® PK/PD Centers of Excellence in China and Japan
PRINCETON, N.J. Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that Peking Union...
View ArticleMammoplasty Using Implants, Safety Must Come First! TL Plastic Surgery
SEOUL, South Korea As mammoplasty using implants is getting popular, people started to pay more attention to its safety. It’s a complex procedure as it covers not only breast augmentation but also...
View ArticleGynesonics Announces Early Completion of Enrollment in the SONATA FDA...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of advanced incision-free solutions for treatment of benign uterine conditions, today announced the...
View ArticleTemasek Invests $250M in Columbia Pacific’s China Operations
SEATTLE Columbia Pacific Management, one of the largest and fastest-growing healthcare providers in Asia, is partnering with Temasek, an investment company based in Singapore, on a joint venture...
View Article世界麻醉师学会联盟(WFSA)签署承诺,以支持患者安全运动到2020年实现零可预防死亡例数的使命
加州尔湾 (美国商业资讯) — 世界麻醉师学会联盟(WFSA)已签署一项行动承诺,宣布其将支持患者安全运动基金会(PSMF)及其在2020年之前杜绝可预防死亡的使命。同时,PSMF正在加入WFSA的SAFE-T(安全麻醉为人人——今天)活动,以促进全球安全及平价麻醉的获取。WFSA将在第五届世界患者安全科技峰会上正式宣布其承诺,此次会议将于2017年2月3-4日在加州达纳点(Dana...
View Article世界麻酔学会連合(WFSA)、患者安全運動の「2020年までの患者死亡の根絶」という使命を支える誓約に署名
米カリフォルニア州アーバイン (ビジネスワイヤ) — 世界麻酔学会連合(WFSA)は、行動への誓約に署名し、患者安全運動財団(PSMF) と、予防可能な死亡を2020年までに根絶するという同財団の使命を支持すると発表しました。同時にPSMFは、世界中で安全かつ求めやすい麻酔へのアクセスを向上させるためのWFSAのSAFE-T(「すべての患者に安全な麻酔を、今日から」、Safe...
View ArticleFirst Patient is Enrolled in Global STEMTRA Trial for Traumatic Brain Injury...
MOUNTAIN VIEW, Calif. & TOKYO SanBio Co., Ltd., a scientific leader in regenerative medicine for neurological disorders, today announced that the first patient in Japan was enrolled in the...
View ArticleColumbia China Celebrates Reopening of Orthopedic Hospital in Shanghai
SHANGHAI Columbia China this week is celebrating the reopening of the 232-bed Shanghai Kaiyuan Orthopedic Hospital as an Orthopedic Center of Excellence operating at the highest international...
View Article面对事实:卒中是可以治疗的
印度海得拉巴 (美国商业资讯) — 世界上每2秒钟就有人发生卒中。卒中是全球第一致残原因和和第二死因。 正确的卒中医护能够挽救生命,但全球并非每个人都能获得平等的挽救生命的治疗。 今天是世界卒中日(2016年10月29日星期六),世界卒中组织(WSO)呼吁全球行动起来减少卒中治疗中的不平等,以帮助挽救数百万生命。 在印度海得拉巴召开的世界卒中大会上,WSO主席Stephen...
View Article事実を直視する:脳卒中は治療可能
印ハイデラバード (ビジネスワイヤ) — 世界中では2秒に1人のペースで誰かが脳卒中を起こしています。脳卒中は世界で障害の主因の第1位、死亡の主因の第2位を占めています。 脳卒中の正しい治療は命を救うことができますが、世界では命を救う治療へのアクセスは誰もが同じというわけではありません。...
View ArticleA.M. Best Special Report: Japan’s Aging Population Drives Private Health...
HONG KONG Japan’s private health insurance market has been actively developed, driven by the robust growth of third-sector insurance products over the past 10 years, according to a new A.M. Best...
View ArticleAtriCure Announces Approval for the cryoICE™ Platform in Japan
MASON, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received approval...
View ArticleCindat and Union Life to Invest in a Welltower U.S. Health Care Real Estate...
TOLEDO, OHIO & BEIJING Welltower Inc. (NYSE:HCN), Cindat Capital Management Limited (“Cindat”) and Union Life Insurance Co. Ltd (“Union Life”) announced today that they have entered into a...
View ArticleエイトリキュアがcryoICE™プラットフォームの日本での承認を発表
米オハイオ州メーソン (ビジネスワイヤ) — 心房細動(Afib)治療と左心耳(LAA)管理における一流イノベーター企業のエイトリキュア(Nasdaq: ATRC)は本日、cryoICE™プラットフォームおよびCRYO2冷凍アブレーションプローブの承認を厚生労働省より取得したと発表しました。承認により、これらの製品が日本市場で初めて提供可能になります。...
View ArticleCustom PCR Master Mixes Ship in 10 Days with New Promega cGMP PCR Kit for...
MADISON, Wis. Now available, the Promega PCR Optimization Kit allows customers to rapidly define their own unique PCR master mix manufactured under cGMP for research or clinical use. The user’s...
View ArticlePhilips and Masimo Sign Multi-Year Business Partnership Agreement in Patient...
AMSTERDAM & IRVINE, Calif. Royal Philips (NYSE: PHG; AEX: PHIA) and Masimo Corporation (NASDAQ: MASI) today announced a wide-ranging, multi-year business partnership involving both companies’...
View Article飞利浦与Masimo签署患者监护和选定治疗解决方案的多年业务伙伴关系协议
阿姆斯特丹和加州尔湾 (美国商业资讯) — 皇家飞利浦(NYSE: PHG; AEX: PHIA)和Masimo公司(NASDAQ:...
View Article